CLINICAL_TRIALS
trial_result
· 2008-03-04
Clinical Trial Update: Humanized LL2IGG to Treat Systemic Lupus Erythematosus [Phase 1]
Summary
Phase 1 trial evaluating a humanized LL2IgG for systemic lupus erythematosus has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Conditions: Systemic Lupus Erythematosus | Phase 1 | Status: COMPLETED